Evidence map›Paper›PMID 36142445›Full record

ArticleInternational journal of molecular sciences2022

The hEag1 K

Beáta Mészáros, Agota Csoti, Tibor G Szanto, Andrea Telek, Katalin Kovács, Agnes Toth, Julianna Volkó, Gyorgy Panyi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Beáta MészárosDepartment of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Life Science Building, Egyetem Ter 1, H-4032 Debrecen, Hungary.
Agota CsotiDepartment of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Life Science Building, Egyetem Ter 1, H-4032 Debrecen, Hungary.
Tibor G SzantoDepartment of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Life Science Building, Egyetem Ter 1, H-4032 Debrecen, Hungary.
Andrea TelekDepartment of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Life Science Building, Egyetem Ter 1, H-4032 Debrecen, Hungary.
Katalin KovácsDepartment of Medical Chemistry, Faculty of Medicine, University of Debrecen, Life Science Building, Egyetem Ter 1, H-4032 Debrecen, Hungary.
Agnes TothDepartment of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Life Science Building, Egyetem Ter 1, H-4032 Debrecen, Hungary.
Julianna VolkóDepartment of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Life Science Building, Egyetem Ter 1, H-4032 Debrecen, Hungary.
Gyorgy PanyiDepartment of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Life Science Building, Egyetem Ter 1, H-4032 Debrecen, Hungary.ORCID 0000-0001-6227-3301
University of Debrecen · HU

Funding

Ministry of Finance, Hungary GINOP-2.3.2-15-2016-00044Ministry of Human Capacities, Hungary EFOP- 3.6.2-16-2017-00006National Research, Development and Innovation Office of Hungary K143071
6 · The paper itself

Abstract

The hEag1 (Kv10.1) K

Indexed as

Bone NeoplasmsOsteosarcomaAstemizoleCell Line, TumorEther-A-Go-Go Potassium ChannelsHumansOsteogenesisPhosphatesRNA, MessengerAstemizoleEther-A-Go-Go Potassium ChannelsPhosphatesRNA, MessengerCa2+ depositionhEag1 potassium channelKv10.1SaOS-2 osteosarcoma cells

Identifiers

PMID36142445
PMCPMC9504018
OpenAlexW4295846795

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.